The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person12

PROVIDENCE DEVELOPMENTS LIMITED

Company · 05382541

20 records in the corpus

WYNN DEVELOPMENTS LIMITED

Company · 10743837

14 records in the corpus

PANATTONI UK DEVELOPMENTS LIMITED

Company · 10892613

18 records in the corpus

WESTCOMBE DEVELOPMENTS LIMITED

Company · 11235987

21 records in the corpus

Cranfield Management Development Limited

Company · 02760241

2 records in the corpus

NIOCORP DEVELOPMENTS LTD

Company

2 records in the corpus

P.M.C. CONSTRUCTION AND DEVELOPMENT SERVICES LIMITED

Company · 01675790

14 records in the corpus

P INVESTMENTS LIMITED

Company · 04881705

17 records in the corpus

PENPOLE EVENTS LIMITED

Company · 12719218

14 records in the corpus

PROVIDENCIA INVESTMENTS LTD

Company · 09657651

18 records in the corpus

Cooneen Defence Limited

Company · NI049695

15 records in the corpus

Identity Events Management Limited

Company · 04217845

14 records in the corpus

Primary record18

fca_pdmr_buy

National Storage Mechanism | Additional information RNS Number : 4175C EDX Medical Group PLC 09 November 2026 9 November 2026 AIM: EDX ("EDX Medical" or the "Company") Director dealing CAMBRIDGE, UK: EDX Medical Group pl

09 Nov 2026 · fca pdmr

PROVIDENCE DEVELOPMENTS LIMITED: ownership and control

PROVIDENCE DEVELOPMENTS LIMITED (company 05382541), incorporated 2005-03-04, status active. Current officers: MELLON, Alastair John Farquharson (director). Persons with significant control: Mr Alastair John Farquharson M

09 Nov 2026 · companies house control

PROVIDENCE DEVELOPMENTS LIMITED: ownership and control

PROVIDENCE DEVELOPMENTS LIMITED (company 05382541), incorporated 2005-03-04, status active. Current officers: MELLON, Alastair John Farquharson (director). Persons with significant control: Mr Alastair John Farquharson M

08 Nov 2026 · companies house control

PROVIDENCE DEVELOPMENTS LIMITED: ownership and control

PROVIDENCE DEVELOPMENTS LIMITED (company 05382541), incorporated 2005-03-04, status active. Current officers: MELLON, Alastair John Farquharson (director). Persons with significant control: Mr Alastair John Farquharson M

07 Nov 2026 · companies house control

TuHURA Biosciences, Inc./NV filed 8-K

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. As previously disclosed, on April 21, 2026, TuHURA Biosciences, Inc. (the “Company”) entered in

06 Nov 2026 · sec daily index

MOLINA HEALTHCARE, INC. filed 8-K

Item 7.01. Regulation FD Disclosure. 2026 Outlook Affirmation Members of the senior management team of Molina Healthcare, Inc. (“Molina” or the “Company”) will be participating in UBS’s Global Healthcare Conference on Mo

06 Nov 2026 · sec daily index

CCO HOLDINGS CAPITAL CORP filed 8-K

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On November 6, 2026, Charter Communications, Inc. issued a press release announcing its results for the third quarter ended September 30, 2026. The following info

06 Nov 2026 · sec daily index

PROVIDENCE DEVELOPMENTS LIMITED: ownership and control

PROVIDENCE DEVELOPMENTS LIMITED (company 05382541), incorporated 2005-03-04, status active. Current officers: MELLON, Alastair John Farquharson (director). Persons with significant control: Mr Alastair John Farquharson M

06 Nov 2026 · companies house control

Bambusa Therapeutics, Inc. filed SCHEDULE 13D

, as amended, (the "Act") is filed as Exhibit 99.1. The Reporting Persons' ownership of the Issuer's securities includes (i) 5,933,787 shares of common stock held directly by the Fund; and (ii) 1,495,971 shares of common

06 Nov 2026 · sec daily index

Crown PropTech Acquisitions filed 8-K

Item 8.01 Other Events. On November 5, 2026, Mkango announced that, on November 4, 2026, the U.S. Securities and Exchange Commission (the “ SEC ”) declared effective the registration statement on Form F-4 (File No. 333-2

06 Nov 2026 · sec daily index

Sandwell Metropolitan Borough Council awarded £1,000,000 to Korn Ferry (UK) Ltd

Sandwell Metropolitan Borough Council awarded a contract to Korn Ferry (UK) Ltd worth £1,000,000 on 2026-11-06. Contract: Transformation Managed Service Provider - AWARD. Transformation Managed Service Provider

06 Nov 2026 · uk procurement

PRECISION BIOSCIENCES INC filed 8-K

Item 8.01 Other Events. On November 5, 2026, Precision BioSciences, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with TD Securities (USA) LLC and Guggenheim Securities, LLC,

06 Nov 2026 · sec daily index

WEST MIDLANDS COMBINED AUTHORITY awarded £881,410 to ESRI (UK) Limited

WEST MIDLANDS COMBINED AUTHORITY awarded a contract to ESRI (UK) Limited worth £881,410 on 2026-08-10. Contract: The Provision of a Geographic Information System (GIS). Transport for West Midlands (TfWM), part of the Wes

06 Nov 2026 · uk procurement

Sandwell Metropolitan Borough Council awarded an undisclosed sum to Korn Ferry (UK) Ltd

Sandwell Metropolitan Borough Council awarded a contract to Korn Ferry (UK) Ltd on 2026-11-06. Contract: Transformation Managed Service Provider - AWARD. Transformation Managed Service Provider The Council

06 Nov 2026 · uk procurement

Black Spade Acquisition III Co filed 8-K

Item 1.01 Entry Into A Material Definitive Agreement. First Amendment to Business Combination Agreement As previously disclosed in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the

05 Nov 2026 · sec daily index

IMMUNIC, INC. filed 8-K

Item 7.01. Regulation FD Disclosure On November 5, 2026, Immunic, Inc. (the “ Company ” or “ Immunic ”) is hosting a Progressive Multiple Sclerosis (PMS) Research and Development Day webinar (the “ PMS R&D Day ”). The PM

05 Nov 2026 · sec daily index

BEACON TOPCO, INC. filed 8-K

Item 1.01 Entry into a Material Definitive Agreement. Amendment to the Merger Agreement As previously disclosed, on September 29, 2025, Beacon Topco, Inc., a Delaware corporation (“ Topco ”), entered into an Agreement an

05 Nov 2026 · sec daily index

Pacira BioSciences, Inc. filed 8-K

Item 7.01. Regulation FD Disclosure. As previously disclosed, on October 8, 2026, Pacira BioSciences, Inc., a Delaware corporation (the “Company” or “Pacira”), entered into the Agreement and Plan of Merger (the “Merger A

05 Nov 2026 · sec daily index